Christelle Colin

1.1k total citations
26 papers, 358 citations indexed

About

Christelle Colin is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Christelle Colin has authored 26 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Christelle Colin's work include Peroxisome Proliferator-Activated Receptors (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Christelle Colin is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Christelle Colin collaborates with scholars based in United States, France and United Kingdom. Christelle Colin's co-authors include Stéphane Flament, Yves Chapleur, Michel Boisbrun, Isabelle Grillier‐Vuissoz, Sandra Kuntz, Sabine Mazerbourg, Tatyana Humle, Srikumar Chellappan, Domenico Coppola and Namrata Bora-Singhal and has published in prestigious journals such as Blood, Bioinformatics and PLoS ONE.

In The Last Decade

Christelle Colin

24 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christelle Colin United States 12 181 73 64 48 33 26 358
Nathalie Favre Switzerland 13 305 1.7× 190 2.6× 21 0.3× 33 0.7× 25 0.8× 19 722
Wendan Xu China 12 165 0.9× 47 0.6× 69 1.1× 31 0.6× 20 0.6× 27 376
Josphin Johnson Australia 8 139 0.8× 27 0.4× 19 0.3× 112 2.3× 10 0.3× 8 354
Seema Grewal United Kingdom 13 322 1.8× 58 0.8× 13 0.2× 35 0.7× 6 0.2× 19 688
Magdalena Mazurkiewicz Sweden 11 410 2.3× 119 1.6× 7 0.1× 48 1.0× 16 0.5× 17 542
Sharon Gross United States 10 122 0.7× 65 0.9× 72 1.1× 7 0.1× 12 0.4× 12 396
Mary E. Abusief United States 9 188 1.0× 202 2.8× 22 0.3× 54 1.1× 7 0.2× 12 838
Catherine Scott United Kingdom 10 239 1.3× 104 1.4× 37 0.6× 33 0.7× 2 0.1× 15 553
О. V. Smirnova Russia 11 118 0.7× 81 1.1× 24 0.4× 25 0.5× 15 0.5× 106 520
Brian T. Jones United States 13 133 0.7× 52 0.7× 43 0.7× 38 0.8× 7 0.2× 19 536

Countries citing papers authored by Christelle Colin

Since Specialization
Citations

This map shows the geographic impact of Christelle Colin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christelle Colin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christelle Colin more than expected).

Fields of papers citing papers by Christelle Colin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christelle Colin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christelle Colin. The network helps show where Christelle Colin may publish in the future.

Co-authorship network of co-authors of Christelle Colin

This figure shows the co-authorship network connecting the top 25 collaborators of Christelle Colin. A scholar is included among the top collaborators of Christelle Colin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christelle Colin. Christelle Colin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Colin, Christelle, Dalia Ercan, Eric A. Welsh, et al.. (2025). A machine learning framework for classifying lipids in untargeted metabolomics using mass-to-charge ratios and retention times. Metabolomics. 21(6). 151–151.
3.
Mazzacurati, Lucia, Guolin Zhang, Christelle Colin, et al.. (2024). SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms. American Journal of Hematology. 99(6). 1040–1055. 1 indexed citations
4.
Gillis, Nancy, Christelle Colin, Ryan M. Putney, et al.. (2024). Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer. The Journal of Infectious Diseases. 230(3). 680–688. 3 indexed citations
5.
Colin, Christelle, Rahul Mhaskar, Shridar Ganesan, et al.. (2023). Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO Precision Oncology. 7(7). e2300208–e2300208. 4 indexed citations
6.
Martin, Alexandra, et al.. (2023). Impact of obesity on chemotherapy dosing of carboplatin and survival of women with ovarian cancer. British Journal of Cancer. 128(12). 2236–2242. 6 indexed citations
7.
Laajala, Teemu D., Federico C. F. Calboli, Kalaimathy Singaravelu, et al.. (2023). A harmonized resource of integrated prostate cancer clinical, -omic, and signature features. Scientific Data. 10(1). 430–430. 2 indexed citations
8.
Bora-Singhal, Namrata, Biswarup Saha, Christelle Colin, et al.. (2020). Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2. Scientific Reports. 10(1). 4722–4722. 72 indexed citations
9.
Maan, Meenu, Neha Jaiswal, Jaya Padmanabhan, et al.. (2020). Tank Binding Kinase 1 modulates spindle assembly checkpoint components to regulate mitosis in breast and lung cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(3). 118929–118929. 12 indexed citations
10.
Colin, Christelle, et al.. (2019). RMC-4550, an Allosteric Inhibitor of SHP2, Displays Therapeutic Efficacy in Pre-Clinical Models of Myeloproliferative Neoplasms. Blood. 134(Supplement_1). 4198–4198. 3 indexed citations
11.
Colin, Christelle, Claudia Cerella, Gérald Monard, et al.. (2018). Biotinylation enhances the anticancer effects of 15d‑PGJ2 against breast cancer cells. International Journal of Oncology. 52(6). 1991–2000. 4 indexed citations
12.
Liu, Yi, Yongbing Zhao, Xiao Wang, et al.. (2016). Foxa1 is essential for mammary duct formation. genesis. 54(5). 277–285. 13 indexed citations
13.
Colin, Christelle, Isabelle Grillier‐Vuissoz, Sandra Kuntz, et al.. (2014). Optimization of troglitazone derivatives as potent anti-proliferative agents: Towards more active and less toxic compounds. European Journal of Medicinal Chemistry. 83. 129–140. 26 indexed citations
14.
Colin, Christelle, Isabelle Grillier‐Vuissoz, Sandra Kuntz, et al.. (2012). Synthesis of new troglitazone derivatives: Anti-proliferative activity in breast cancer cell lines and preliminary toxicological study. European Journal of Medicinal Chemistry. 51. 206–215. 57 indexed citations
15.
Colin, Christelle, Isabelle Grillier‐Vuissoz, Michel Boisbrun, et al.. (2010). New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines. Breast Cancer Research and Treatment. 124(1). 101–110. 22 indexed citations
16.
Humle, Tatyana, et al.. (2010). Group Release of Sanctuary Chimpanzees (Pan troglodytes) in the Haut Niger National Park, Guinea, West Africa: Ranging Patterns and Lessons So Far. International Journal of Primatology. 32(2). 456–473. 22 indexed citations
18.
Colin, Christelle, et al.. (2004). Les infirmières de santé publique au Québec : une contribution essentielle et… méconnue. Santé Publique. Vol. 16(2). 263–272. 3 indexed citations
20.
Colin, Christelle. (2004). La santé publique au Québec à l'aube du XXIe siècle. Santé Publique. Vol. 16(2). 185–195. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026